首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   837篇
  免费   62篇
  国内免费   9篇
耳鼻咽喉   4篇
儿科学   35篇
妇产科学   13篇
基础医学   90篇
口腔科学   34篇
临床医学   69篇
内科学   192篇
皮肤病学   18篇
神经病学   30篇
特种医学   106篇
外科学   123篇
综合类   26篇
预防医学   61篇
眼科学   6篇
药学   71篇
中国医学   1篇
肿瘤学   29篇
  2022年   6篇
  2021年   19篇
  2020年   10篇
  2019年   12篇
  2018年   19篇
  2017年   14篇
  2016年   20篇
  2015年   17篇
  2014年   20篇
  2013年   44篇
  2012年   32篇
  2011年   29篇
  2010年   35篇
  2009年   31篇
  2008年   25篇
  2007年   19篇
  2006年   25篇
  2005年   19篇
  2004年   19篇
  2003年   29篇
  2002年   19篇
  2001年   14篇
  2000年   15篇
  1999年   23篇
  1998年   37篇
  1997年   27篇
  1996年   23篇
  1995年   14篇
  1994年   24篇
  1993年   24篇
  1992年   12篇
  1991年   9篇
  1990年   14篇
  1989年   15篇
  1988年   18篇
  1987年   12篇
  1986年   16篇
  1985年   9篇
  1984年   14篇
  1983年   15篇
  1982年   10篇
  1981年   13篇
  1980年   17篇
  1979年   6篇
  1978年   7篇
  1977年   7篇
  1976年   14篇
  1975年   7篇
  1974年   5篇
  1970年   4篇
排序方式: 共有908条查询结果,搜索用时 15 毫秒
11.
Rezaie  AR; Esmon  CT 《Blood》1994,83(9):2526-2531
Protein C is a vitamin K-dependent plasma serine protease zymogen, which upon activation, functions as an anticoagulant. Protein C activation is catalyzed by a complex of thrombin (T) with thrombomodulin (TM). This activation is Ca(2+)-dependent, but Ca2+ inhibits protein C activation by thrombin alone. In most proteases, specificity is determined primarily by the residues that lie near the scissile bond. In protein C, the P2 position is Pro, whereas in the fibrinogen A chain, P2 is Val. We have expressed a Pro-->Val mutant of protein C (P168V) in mammalian cells. At saturating Ca2+, the P168V and wild-type proteins were activated by the T-TM complex equivalently, but half maximal rates of activation were obtained at 50 mumol/L Ca2+ for wild type and approximately 5 mmol/L Ca2+ for the P168V mutant. In the absence of TM, Ca2+ no longer inhibited the activation of the P168V mutant. These results indicate that Pro168 influences the Ca(2+)- dependent conformational changes in protein C that control activation. Recently, a patient with thrombotic complications has been identified with a Pro168-->Leu substitution. Both the P168V and the P168L mutation lead to impaired secretion caused by retention within the cell.  相似文献   
12.

Background

Ischemic hepatitis is a devastating cause of acute liver injury. Data are limited regarding its incidence and outcomes.

Methods

Systematic review and meta-analysis of studies from PubMed, EMBASE, and Web of Science with specific search terms. Inclusion criteria included case series with >10 patients and clear case definition (especially liver enzyme levels >10 times the upper limit of normal).

Results

Twenty-four papers met inclusion criteria. A total of 1782 cases were identified in these papers (mean 78 per paper, range 12-322). The pooled average age of the included patients was 64.2 years, and their mean peak aspartate aminotransferase level, alanine aminotransferase level, and total bilirubin were 2423 IU/L, 1893 IU/L, and 2.55 mg/dL, respectively. Ischemic hepatitis was present in 2 of every 1000 admissions; including 2.5 of every 100 intensive care unit admissions and 4 of 10 admissions associated with an aminotransferase level >10 times the upper limit of normal. The pooled proportions of patients with ischemic hepatitis who had a predisposing acute cardiac event or sepsis were 78.2% and 23.4%, respectively. The proportion of patients with a documented hypotensive event of any duration was 52.9%. Overall, the pooled rate of survival to discharge was 51% (range 23.1%-85.7%).

Conclusions

Ischemic hepatitis is a common cause of severe acute liver injury and is associated with a significant risk of in-hospital death. A major opportunity in the management of ischemic hepatitis is recognition of the condition without documented hypotension.  相似文献   
13.
14.
15.
A set of 11 polymorphic microsatellite loci were developed for Kunzea pulchella, a plant species endemic to granite outcrops in Western Australia. Genomic sequences were obtained from next generation (454) sequencing. A total of 20 microsatellite markers were then chosen for amplification and genotyping trials in individuals across the species range. Eleven of these loci were selected for analysis based on amplification and genotyping success. All were polymorphic with 4–10 alleles per locus (mean = 5.9). Expected and observed heterozygosity ranged from 0.29 to 0.92 averaging 0.606 and 0.690 respectively. Loci were in Hardy–Weinberg equilibrium (P < 0.05) except for two which showed evidence for null alleles. Linkage disequilibrium was evident in three loci pair combinations. These polymorphic microsatellite markers will be valuable for analysis of population genetic structure and connectivity in K. pulchella.  相似文献   
16.
Ten polymorphic microsatellite loci were developed for the tetraploid plant species Stypandra glauca which is common on granite outcrops in Western Australia. Amplification and genotyping trials were conducted on 48 individuals from two sampling localities. All 10 loci revealed multi-banding patterns with up to 4 bands visible in individuals consistent with tetraploidy. The number of alleles per locus ranged from 6 to 32 (mean = 12.5). The proportion of observed heterozygotes at each locus ranged from 0.32 to 0.98 (mean = 0.73). These polymorphic microsatellite markers will facilitate further analysis of population genetic structure and connectivity in Stypandra glauca.  相似文献   
17.
18.
19.
20.
The purpose of this review is to evaluate the influence of bariatric surgery on the use and pharmacokinetics of some frequently used drugs. A PubMed literature search was conducted. Literature was included on influence of bariatric surgery on pharmacoepidemiology and pharmacokinetics. Drug classes to be searched for were antidepressants, antidiabetics, statins, antihypertensive agents, corticosteroids, oral contraceptives, and thyroid drugs. A reduction in the use of medication by patients after bariatric surgery has been reported for various drug classes. Very few studies have been published on the influence of bariatric surgery on the pharmacokinetics of drugs. After bariatric surgery, theoretically, reduced drug absorption may occur. Correct dosing and choosing the right dosage form for drugs used by patients after bariatric surgery are necessary for optimal pharmacotherapy. Therefore, more clinical studies are needed on the influence of bariatric surgery on the pharmacokinetics of major drugs.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号